General Electric’s shares surged more than 5% on Monday after the Company announced the sale of its biopharma business to Danahar (DHR) for a $21.4 billion all-cash deal. The company also announced its plans to use the cash received from the deal to defray its debts.
According to the terms of the deal, Danaher will pay $21 billion in cash to GE but at the same time it will also assume certain GE pension liabilities.
Expected to be complete by the fourth quarter, the deal is likely to see GE Life Sciences unit is expected to join Danaher’s Life Science as a stand-alone business. GE biopharma unit is expected to generate about $3.2 billion in revenue this year.
After the announcement, GE’s share traded as high as $11.75 in early trading before shedding some gains to close up 6.4% at $10.82 a share. Danaher’s stock also jumped 8.5% to close at $123.15 a share.
GE has already seen yields on its debt bonds fall to low levels along with a decline in risk premium demanded by investors in exchange for holding GE paper. But following the announcement, GE saw one of its most active bonds – the $11.5 billion of 4.418% notes due in November 2035 – jump 2.6 points in price to regain the $0.90 on the dollar level for the first time since October.
The RSI Oscillator for GE moved out of oversold territory on December 19, 2024. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 18 similar instances when the indicator left oversold territory. In of the 18 cases the stock moved higher. This puts the odds of a move higher at .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 56 cases where GE's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on December 24, 2024. You may want to consider a long position or call options on GE as a result. In of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for GE just turned positive on December 24, 2024. Looking at past instances where GE's MACD turned positive, the stock continued to rise in of 56 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GE advanced for three days, in of 326 cases, the price rose further within the following month. The odds of a continued upward trend are .
GE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
GE moved below its 50-day moving average on November 27, 2024 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for GE entered a downward trend on December 19, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 71, placing this stock better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. GE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.833) is normal, around the industry mean (8.271). P/E Ratio (33.824) is within average values for comparable stocks, (56.258). Projected Growth (PEG Ratio) (1.696) is also within normal values, averaging (2.342). Dividend Yield (0.005) settles around the average of (0.016) among similar stocks. P/S Ratio (2.712) is also within normal values, averaging (7.991).
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of products for the generation, transmission, distribution, control and utilization of electricity; manufactures aircraft engines and medical equipment
Industry AerospaceDefense